The ACT EU Steering Group, established in March 2022, is composed of members from the European Commission, European Medicines Agency (EMA), Heads of Medicines Agencies (HMA), and the Network Portfolio Advisory Group (NPAG). The chair is provided by the European Commission.
The Steering Group has a decision-making role and reports to the EMA Management Board and HMA.
The mandate and composition of the Steering Group can be found below.
List of members
Chair
| Bruno Gautrais | European Commission, Directorate-General for Health and Food Safety (DG SANTE) |
Members
| Linda Abdelall | European Commission, Directorate-General for Health and Food Safety (DG SANTE) |
| Peter Arlett | European Medicines Agency (EMA) |
| Karl Broich | Federal Institute For Drugs And Medical Devices (BfArM), Germany |
| Isabelle Clamou | European Commission, Directorate-General for Health and Food Safety (DG SANTE) |
| María Jesús Lamas Díaz | Agency of Medicines and Medical Products (AEMPS), Spain Chair of the Head of Medicines Agencies (HMA) Management Group |
| Marianne Lunzer | Chair of the Heads of Medicines Agencies' Clinical Trials Coordination Group |
| Lorraine Nolan | Health Products Regulatory Authority, Ireland Chair of the European Medicines Agency's Management Board |
| Iordanis Gravanis | European Medicines Agency (EMA) |
| Bruno Sepodes | National Authority Of Medicines And Health Products (Infarmed), Portugal Chair of the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) |
| Stan van Belkum | Central Committee on Research Involving Human Subjects (CCMO), Netherlands |
